241 related articles for article (PubMed ID: 30704101)
1. Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors.
Wen H; Qin W; Yang G; Guo Y
Molecules; 2019 Jan; 24(3):. PubMed ID: 30704101
[TBL] [Abstract][Full Text] [Related]
2. [Design, synthesis and 5-HT/NE dual reuptake inhibitory activity of aromatic heterocyclic arylamidine derivatives].
Wen H; Yang J; Zhang JJ; Wang YF; Ji CX; Yang GZ
Yao Xue Xue Bao; 2009 Mar; 44(3):303-8. PubMed ID: 19449528
[TBL] [Abstract][Full Text] [Related]
3. [Design, synthesis and pharmacological investigation of isoindoline derivatives as 5-HT/NE double reuptake inhibitors].
Wen H; Shi Y; Dong JW; Guo YS; Zang JJ; Yang GZ
Yao Xue Xue Bao; 2015 Sep; 50(9):1148-55. PubMed ID: 26757552
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Zhou AN; Xiao Y; Zhang QW; Li JQ
Eur J Med Chem; 2018 Jan; 144():701-715. PubMed ID: 29291438
[TBL] [Abstract][Full Text] [Related]
5. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
6. Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.
Tamiya J; Dyck B; Zhang M; Phan K; Fleck BA; Aparicio A; Jovic F; Tran JA; Vickers T; Grey J; Foster AC; Chen C
Bioorg Med Chem Lett; 2008 Jun; 18(11):3328-32. PubMed ID: 18445525
[TBL] [Abstract][Full Text] [Related]
7. Neuropharmacological and antidepressant-like effects of ZY-1408: A novel serotonin/norepinephrine reuptake inhibitor and serotonin receptor 2C antagonist.
Gao N; Tiliwaerde M; Zheng W; Xiong J; Li X; Jin Z
Neuropharmacology; 2021 Jan; 182():108376. PubMed ID: 33122031
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and 5-HT reuptake inhibition activity of biarylbenzamidine derivatives].
Qin F; Wang NS; Yang J; Zhang JJ; Wang YF; Yang GZ
Yao Xue Xue Bao; 2008 Jun; 43(6):619-25. PubMed ID: 18822965
[TBL] [Abstract][Full Text] [Related]
9. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
[TBL] [Abstract][Full Text] [Related]
10. First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants.
Ryckmans T; Balançon L; Berton O; Genicot C; Lamberty Y; Lallemand B; Pasau P; Pirlot N; Quéré L; Talaga P
Bioorg Med Chem Lett; 2002 Jan; 12(2):261-4. PubMed ID: 11755367
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: serotonin reuptake inhibition and 5-HT1A receptor antagonism.
Oficialdegui AM; Martinez J; Pérez S; Heras B; Irurzun M; Palop JA; Tordera R; Lasheras B; del Río J; Monge A
Farmaco; 2000 May; 55(5):345-53. PubMed ID: 10983279
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor.
Xue R; Jin ZL; Chen HX; Yuan L; He XH; Zhang YP; Meng YG; Xu JP; Zheng JQ; Zhong BH; Li YF; Zhang YZ
Eur Neuropsychopharmacol; 2013 Jul; 23(7):728-41. PubMed ID: 22748419
[TBL] [Abstract][Full Text] [Related]
13. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
[TBL] [Abstract][Full Text] [Related]
14. N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.
Jonathan Fray M; Bish G; Brown AD; Fish PV; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2006 Aug; 16(16):4345-8. PubMed ID: 16750359
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Xiao Y; Zhang QW; Li JQ
Bioorg Med Chem Lett; 2017 Dec; 27(24):5420-5423. PubMed ID: 29138029
[TBL] [Abstract][Full Text] [Related]
16. Novel 5-HT
Canale V; Partyka A; Kurczab R; Krawczyk M; Kos T; Satała G; Kubica B; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Popik P; Zajdel P
Bioorg Med Chem; 2017 May; 25(10):2789-2799. PubMed ID: 28391970
[TBL] [Abstract][Full Text] [Related]
17. Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
Andrews M; Brown A; Chiva JY; Fradet D; Gordon D; Lansdell M; MacKenny M
Bioorg Med Chem Lett; 2009 Oct; 19(20):5893-7. PubMed ID: 19740658
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ
Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181
[TBL] [Abstract][Full Text] [Related]
19. N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.
Wakenhut F; Fish PV; Fray MJ; Gurrell I; Mills JE; Stobie A; Whitlock GA
Bioorg Med Chem Lett; 2008 Aug; 18(15):4308-11. PubMed ID: 18625557
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 1-(4-(piperazin-1-yl)phenyl)pyridin-2(1H)-one derivatives as potential SSRIs.
Xu T; Xue Y; Lu J; Jin C
Eur J Med Chem; 2021 Nov; 223():113644. PubMed ID: 34182358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
